Kyu Rhee: Using Watson's Technology in Oncology and Endocrinology

At the recent ASCO conference in Chicago, it was announced that IBM Watson Health would be used to help with cancer treatment. A similar announcement was made at the American Diabetes Association's annual meeting in New Orleans.

Speaking at the Louisiana meeting Kyu Rhee, MD, MPP, chief health officer for IBM Watson Health, discussed how the programs would be similar but also how the unique challenges associated with the treatment of diabetes would be addressed in this collaboration as well.